Table 1. Sociodemographical data of 170 kidney recipients and donors.
| Overall | Primary function | DGF | p | |
|---|---|---|---|---|
| N = 170 | N = 118 | N = 52 | ||
| Patient baseline/preoperative data | ||||
| Recipient sex (N—female) | 61 (36%) | 44 (37%) | 17 (33%) | 0.6 |
| Recipient age (Mean / SD) | 55 (14) | 54 (14) | 59 (12) | 0.02 |
| Donor age (Mean / SD) | 54 (16) | 52 (15) | 60 (15) | <0.001 |
| HLA missmatches (Mean / SD) | 3 (1.5) | 3 (1.6) | 4 (1.3) | 0.08 |
| Ischemia time (minutes, Mean / SD) | 763 (329) | 716 (347) | 867 (258) | 0.002 |
| Charlson Comorbidity Index (Mean / SD) | 2.8 (1.2) | 2.7 (1.1) | 3.1 (1.5) | 0.1 |
| Type of Dialysis (N—HD) | 113 (67%) | 74 (74%) | 39 (85%) | 0.2 |
| Duration of Dialysis (months, mean / SD) | 45 (28) | 42 (30) | 51 (24) | 0.09 |
| Diuresis pretransplant (N—yes) | 100 (59%) | 71 (69%) | 29 (62%) | 0.4 |
| Diuresis pretransplant (lt, median / IQR) | 0.9 (1.5) | 1.0 (1.7) | 0.7 (1.2) | 0.09 |
| Living donation | 20 (12%) | 20 (17%) | 0 | |
| Clinical outcome | ||||
| Episode of acute rejection | 4 (2%) | 0 | 4 (8%) | |
| Graft loss after 1 year | 14 (8%) | 6 (5%) | 8 (15%) | |
| Death after 1 year | 9 (5%) | 5 (4%) | 4 (8%) | |
| Graft loss after 2 years | 19 (11%) | 7 (6%) | 12 (23%) | |
| Death after 2 years | 11 (7%) | 5 (4%) | 6 (12%) | |
| Graft loss after 5 years | 30 (18%) | 14 (12%) | 16 (31%) | |
| Death after 5 years | 15 (9%) | 8 (7%) | 7 (14%) | |
| initial immonosuppression | ||||
| CNI, MP, MMF | 37 (22%) | 31 (26%) | 6 (12%) | |
| Basiliximab, CNI, MP, MMF | 128 (75%) | 83 (70%) | 45 (87%) | |
| other | 5 (3%) | 4 (3%) | 1 (2%) | |
DGF: delayed graft function; SD: standard deviation; CNI: calcineurine inhibitors; MP: Methylprednisolon; MMF: Mycophenolatmofetil; IQR: interquartile range; HD: Haemodialysis